Sonoma Pharmaceuticals, Inc.
SNOA
$2.76
$0.010.20%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 11.75% | 12.46% | -8.57% | 27.27% | -7.16% |
| Total Depreciation and Amortization | 3.03% | 2.86% | -7.69% | -24.39% | -26.67% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -378.57% | 12.60% | -204.93% | 1,458.62% | -68.18% |
| Change in Net Operating Assets | -93.09% | -134.91% | -456.52% | -82.77% | 485.98% |
| Cash from Operations | -235.22% | -279.38% | -120.94% | -162.50% | 151.18% |
| Capital Expenditure | -2,250.00% | 61.54% | -2,020.00% | -361.11% | -100.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -2,250.00% | 61.54% | -2,020.00% | -361.11% | -100.00% |
| Total Debt Issued | -- | -- | -- | -26.54% | -- |
| Total Debt Repaid | 31.71% | 31.97% | 31.93% | 13.83% | 35.94% |
| Issuance of Common Stock | -66.33% | -98.66% | -96.95% | -85.71% | -45.18% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -70.34% | -104.29% | -109.12% | -61.09% | -46.28% |
| Foreign Exchange rate Adjustments | 212.39% | 148.41% | 258.91% | 154.29% | -301.79% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -140.93% | -138.28% | -228.20% | -80.89% | 330.48% |